 SHANGHAI and MIAMI, Sept. 14, 2021 GLOBE NEWSWIRE -- LeaderMed Health Group Limited, a pharmaceutical development company with operations based in Asia, and OPKO Health, Inc. NASDAQ: OPK, a diversified healthcare company focused on diagnostics and pharmaceuticals, announce the formation of a joint venture to develop, manufacture and commercialize two of OPKOs clinical stage, long-acting drug products in Greater China and eight other Asian territories. 